The U.S. Judicial Panel on Multidistrict Litigation (JPML) has denied a request to centralize and consolidate all lawsuits filed in the federal court system against insurance companies who have denied business interruption coverage following the COVID-19 pandemic, indicating that the large number of insurers involved and lack of overlapping parties in the lawsuits would result…
Read more
Lawyers nationwide indicate that an influx of small business owners are planning to file lawsuits over business interruption insurance claim denials, as several insurance companies are attempting to exclude coverage for losses due to the coronavirus outbreak. Many businesses are reporting they have experienced difficulties getting insurance companies to honor policies sold in recent years,…
Read more
Merck & Co. continues to face a growing number of lawsuits filed by individuals nationwide who say they suffered shingles outbreaks after receiving a vaccine injection, which included a version of the live virus that was not sufficiently weakened to avoid causing the very injury it was intended to prevent. In complaint (PDF) filed this…
Read more
According to allegations raised in a recently filed product liability lawsuit, complications from the shingles vaccine resulted in zoster-related visions loss for a North Carolina user. A Complaint (pdf) was filed by Terry Green in the U.S. District for the Eastern District of Pennsylvania on September 4, indicating the Zostavax vaccine manufactured by Merck &…
Read more
In the wake of a recent Belviq recall, which removed the controversial diet drug from the market after it was linked to a risk of cancer, a number of consumers and lawyers are likely to file class action lawsuits that seek medical monitoring, as well as individual injury lawsuits for those who have already developed…
Read more
With more than 1,800 Zostavax shingles vaccine lawsuits pending in the federal court system, parties involved in the litigation have selected four claims that will be prepared for a second wave of bellwether trials, which are expected to go before juries in mid-2022. Each of the claims raise similar allegations, indicating that Merck & Co. failed to…
Read more
Plaintiffs are pushing back against an attempt by generic drug manufacturers and repackagers to dismiss ranitidine class action lawsuits filed over the risk of cancer from high levels of the chemical byproduct found in all versions of the heartburn drug, which was more commonly known by the brand name Zantac. Over the past year, ranitidine…
Read more
Exposure to high levels of ozone air pollution may increase the risk of cardiac arrest, according to the findings of new research. In a study scheduled to be presented next week at the American Heart Association Resuscitation Science Symposium, researchers with Saint Luke’s Mid America Heart Institute indicate that ozone exposure not only increases the…
Read more
The findings of a new study highlight the consequences which may result from a delayed cancer diagnosis, indicating even a one month failure to detect cancer could be the difference between life and death for some patients. In a study published earlier this month in the medical journal The BMJ, Canadian researchers indicate even a…
Read more
The findings of a new study appear to confirm that surgical breast implant removal is the best way to treat a rare type of cancer linked to the design of certain recalled products with a textured surface. Last year, Allergan was forced to issue worldwide breast implant recalls which impacted its entire line of “Biocell” macrotextured…
Read more
